Open-label Study of Initial and Repeat Treatment Cycles of Hylan G-F 20 in Patients with Symptomatic Knee Osteoarthritis

Fig. (2) Proportion of patients responding at weeks 4, 12, and 26 in the total population, and in the initial course and second course groups.